Development of a PROTAC Targeting Chk1
Sandipan Roy Chowdhury, Patrick Chuong, Victoria E. Mgbemena, Alexander Statsyuk
Abstract
A series of Chk1 degraders were designed and synthesized. The degraders were developed through the conjugation of a promiscuous kinase binder and thalidomide. One of the degraders PROTAC-2 was able to decrease Chk1 levels in a concentration-dependent manner in A375 cells. The developed probes can be useful for the development of selective and more potent Chk1 degraders.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Electrophilic Multi-Kinase Probes Identify Degradation and Aspartate Conjugation of ULK1
Nur Mehpare Kocatürk, Adam L. Pinto, … William Farnaby·bioRxiv·May 5, 2026
- Efficiency and localisation of AURKA degradation by PROTACs is modulated by deubiquitinases UCHL5 and target-selective OTUD6A
Annabel Cardno, Karen Roberts, Catherine Lindon·bioRxiv·Apr 23, 2025
- A cell-based degrader assessment platform facilitates discovery of functional NUDT5 PROTACs
Seher Alam, Maria Joao Almeida A Silva Pires, … Mikael Altun·bioRxiv·Jun 13, 2025
- Chemically Induced Degradation of Native Proteins by Direct Recruitment to the 26S Proteasome
Madeline Balzarini, Weijun Gui, … Thomas J. Kodadek·bioRxiv·Jul 19, 2023
- Chemoproteomics-Enabled Discovery of a Covalent Molecular Glue Degrader Targeting NF-κB
E. A. King, Y. Cho, … D. K. Nomura·bioRxiv·May 18, 2022
- Harnessing PROTAC technology to combat stress hormone receptor activation
Mahshid Gazorpak, Karina M. Hugentobler, … Katharina Gapp·Nature CommunicationsPeer-reviewed·Dec 9, 2023